Process Industries Mitsubishi Chemical Holdings Corp. Business Summary
Mitsubishi Chemical Holdings Corp. engages in the management of its group companies. It operates through the following segments: Functional Products, Chemicals, Industrial Gas, and Healthcare. The Functional Products segment sells electronics, displays, films, environment and life solutions, molding materials, polymers, chemicals, and new energy to domestic and overseas customers. The Chemicals segment markets methyl methacrylate, petrochemicals, and carbon. The Industrial Gas segment offers gas for the steel, chemical, and electronics industries. The Healthcare segment manufactures and sells pharmaceuticals, diagnostic reagents, and clinical testing products. The company was founded on October 3, 2005 and is headquartered in Tokyo, Japan.
Financial Highlights
Mar 2020
JPY USD Revenue 3,580.51B 32,931.56M Gross Profit 987,263M 9,080.30M Operating income 186,691M 1,717.08M Income before tax 122,003M 1,122.11M Net income 37,185M 342.00M EBITDA 426,515M 3,922.85M Diluted EPS 35.20 0.32 Dividends Per Share 32 0.29 Total Assets 5,132.14B 47,539.70M Total liabilities 3,681.32B 34,100.50M Total equity 1,170.22B 10,839.90M Operating cash flow 452,003M 4,157.27M Currency in JPY Currency in USD
Historical Data Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
3,543.35B
3,376.05B
3,724.40B
3,840.34B
3,580.51B
Gross Profit
1,015.04B
1,009.39B
1,120.06B
1,074.52B
987,263M
Operating income
295,965M
287,903M
355,745M
297,750M
186,691M
Income before tax
238,808M
241,379M
344,077M
284,846M
122,003M
Net income
125,227M
153,673M
211,788M
167,058M
37,185M
EBITDA
478,621M
461,943M
534,640M
497,082M
426,515M
Diluted EPS
35.03
105.95
136.05
110.04
35.20
Dividends Per Share
15
20
32
40
32
Total Assets
4,223.77B
4,463.54B
4,701.41B
5,572.50B
5,132.14B
Total liabilities
2,627.62B
2,765.35B
2,781.92B
3,546.65B
3,681.32B
Total equity
972,197M
1,091.39B
1,285.75B
1,377.94B
1,170.22B
Operating cash flow
299,612M
396,643M
397,940M
415,575M
452,003M
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
29,507.20M
31,176.79M
33,603.94M
34,630.52M
32,931.56M
Gross Profit
8,452.80M
9,321.47M
10,105.90M
9,689.62M
9,080.30M
Operating income
2,464.64M
2,658.69M
3,209.75M
2,684.98M
1,717.08M
Income before tax
1,988.66M
2,229.05M
3,104.47M
2,568.61M
1,122.11M
Net income
1,042.82M
1,419.12M
1,910.88M
1,506.45M
342.00M
EBITDA
3,985.70M
4,265.89M
4,823.85M
4,482.46M
3,922.85M
Diluted EPS
0.29
0.97
1.22
0.99
0.32
Dividends Per Share
0.12
0.18
0.28
0.36
0.29
Total Assets
37,579.73M
40,056.95M
44,206.99M
50,345.65M
47,539.70M
Total liabilities
23,378.46M
24,816.92M
26,158.19M
32,042.77M
34,100.50M
Total equity
8,649.82M
9,794.47M
12,089.79M
12,449.26M
10,839.90M
Operating cash flow
2,495.01M
3,662.86M
3,590.46M
3,747.47M
4,157.27M
Valuation Measures
Mar 2020
PER 16.87 ROA 0.69% ROE 2.91% Operating margin 5.21% Profit margin 1.03%
Key executives
President & Representative Director:
Jean-Marc Gilson
CFO, Director & Managing Executive Officer:
Hidefumi Date
Director & Chief Compliance Officer:
Ken Fujiwara
Executive Officer, Head-Mergers & Acquisitions:
Tsutomu Yoshida
Group Manager-Business Administration Office:
Hajime Komori Shareholders
Mitsubishi Chemical Holdings Corp. (5.5%)
Meiji Yasuda Life Insurance Co. (4.2%)
Sumitomo Mitsui Trust Asset Management Co., Ltd. (4.1%)
Mitsubishi UFJ Trust & Banking Pension Fund (3.8%)
Nomura Asset Management Co., Ltd. (3.8%)
Nippon Life Insurance Co. (2.8%)
BlackRock Fund Advisors (2.5%)
Nikko Asset Management Co., Ltd. (2.2%)
The Vanguard Group, Inc. (2.0%)
Mitsubishi UFJ Financial Group, Inc. (1.8%)
Related Companies
Mitsubishi Chemical Hldgs. Restricted Stock Compensation Plan
Nippon Gases Euro-Holdings SL
MCPP Innovation LLC
Diamond Edge Ventures, Inc.
Mitsubishi Chemical Holdings Board Incentive Plan
Verbatim Corp.
Mitsubishi Chemical Imaging Corp.
MEP Technical Center Asia Ltd.
MCC Group Holdings (UK) Ltd.
Life Science Institute, Inc.
Mitsubishi Chemical Holdings Europe GmbH
AmperVertice Lda.
Mitsubishi Plastics Agricultural Film Technology Wuxi Co. Ltd.
Ryoukou Industrial Co. Ltd.
Mitsubishi Chemical Analysis Co. Ltd.
Rhombic Corp. (Japan)
Verbatim Southern Africa
Mitsubishi Chemical Holdings (Beijing) Co. Ltd.
Tai Young High Tech Co. Ltd.
MCC PTA Asia Pacific Pte Ltd.
Mitsubishi Chemical Holdings America, Inc.
Advanced Plastics Compounds Singapore Pte Ltd.
PT Mitsubishi Chemical Indonesia
Yoshitomi Engineering Ltd.
Mitsubishi Chemical Hldgs Business Association
Kaiteki Institute, Inc.
Mitsubishi Chemical Infonics Pte Ltd.
Nihon Gosei Sangyo KK
Ryoju Corp.
Mitsubishi Chemical Agri, Inc.
Competitors
DuPont de Nemours, Inc.
Sumitomo Chemical Co., Ltd.
LG Chem Ltd.
Eastman Chemical Company
Arkema SA
Kolon Industries, Inc.
Kolon Life Science Inc.
Covestro AG
Celanese Corporation
Sinochem International Corporation Class A
Polyplex (Thailand) Public Co. Ltd.
Chemocentryx, Inc.
UFlex Limited
Acorda Therapeutics, Inc.
Adamas Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Class A
Linde plc
Fuwei Films (Holdings) Co., Ltd.
Cytokinetics, Incorporated
Mechema Chemicals International Corp.
Shenzhen Capchem Technology Co., Ltd. Class A
Tredegar Corporation
Voyager Therapeutics, Inc.
FibroGen, Inc.
Valneva SE
Ultra Clean Holdings, Inc.
BiondVax Pharmaceuticals Ltd. Sponsored ADR
OCI Partners LP
Orphazyme A/S
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 7 May, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
